Analysts’ Updated EPS Estimates for March 3rd (AAP, AAPL, ABCL, ALDX, ALMS, ALT, AMC, ANIP, APGE, APLS)

Analysts’ updated eps estimates for Monday, March 3rd:

Advance Auto Parts (NYSE:AAP) had its outperform rating reaffirmed by analysts at Wedbush. The firm currently has a $55.00 price target on the stock.

Apple (NASDAQ:AAPL) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $325.00 price target on the stock.

AbCellera Biologics (NASDAQ:ABCL) had its hold rating reiterated by analysts at Benchmark Co..

Aldeyra Therapeutics (NASDAQ:ALDX) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $10.00 price target on the stock.

Alumis (NASDAQ:ALMS) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $19.00 price target on the stock.

Altimmune (NASDAQ:ALT) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $12.00 target price on the stock.

AMC Entertainment (NYSE:AMC) had its hold rating reiterated by analysts at Benchmark Co..

ANI Pharmaceuticals (NASDAQ:ANIP) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $94.00 target price on the stock.

Apogee Therapeutics (NASDAQ:APGE) had its outperform rating reiterated by analysts at Wedbush. They currently have a $90.00 target price on the stock.

Apellis Pharmaceuticals (NASDAQ:APLS) had its buy rating reissued by analysts at HC Wainwright. They currently have a $57.00 target price on the stock.

Avadel Pharmaceuticals (NASDAQ:AVDL) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $19.00 price target on the stock.

Axsome Therapeutics (NASDAQ:AXSM) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $153.00 target price on the stock.

Best Buy (NYSE:BBY) had its neutral rating reiterated by analysts at Wedbush. Wedbush currently has a $90.00 target price on the stock.

Beacon Roofing Supply (NASDAQ:BECN) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $140.00 target price on the stock.

Boston Scientific (NYSE:BSX) had its hold rating reiterated by analysts at Needham & Company LLC.

Can-Fite BioPharma (NYSE:CANF) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $10.00 price target on the stock.

Calumet Specialty Products Partners (NASDAQ:CLMT) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $33.00 price target on the stock.

Costco Wholesale (NASDAQ:COST) had its outperform rating reiterated by analysts at Telsey Advisory Group. The firm currently has a $1,100.00 price target on the stock.

Crescent Energy (NYSE:CRGY) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $17.00 price target on the stock.

Carvana (NYSE:CVNA) had its overweight rating reaffirmed by analysts at Stephens. Stephens currently has a $300.00 price target on the stock.

Deere & Company (NYSE:DE) had its neutral rating reissued by analysts at Robert W. Baird. They currently have a $501.00 target price on the stock.

Dollar General (NYSE:DG) had its hold rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a $80.00 price target on the stock, down from their previous price target of $90.00.

Domino’s Pizza (NASDAQ:DPZ) had its equal weight rating reissued by analysts at Stephens. The firm currently has a $440.00 price target on the stock.

Eventbrite (NYSE:EB) had its buy rating reiterated by analysts at BWS Financial. They currently have a $7.00 price target on the stock.

Excelerate Energy (NYSE:EE) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $36.00 target price on the stock.

Enlivex Therapeutics (NASDAQ:ENLV) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $13.00 target price on the stock.

4D Molecular Therapeutics (NASDAQ:FDMT) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $36.00 target price on the stock.

FTAI Aviation (NYSE:FTAI) had its hold rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $123.00 target price on the stock, up from their previous target price of $100.00.

Greif (NYSE:GEF) had its hold rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $65.00 price target on the stock, down from their previous price target of $71.00.

International Consolidated Airlines Group (LON:IAG) had its overweight rating reiterated by analysts at JPMorgan Chase & Co..

Intrusion (NASDAQ:INTZ) had its neutral rating reaffirmed by analysts at HC Wainwright. They currently have a $1.00 target price on the stock.

Janux Therapeutics (NASDAQ:JANX) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $70.00 target price on the stock.

Kimbell Royalty Partners (NYSE:KRP) had its market perform rating reiterated by analysts at Raymond James.

Longeveron (NASDAQ:LGVN) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $10.00 price target on the stock.

Southwest Airlines (NYSE:LUV) had its underweight rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $25.00 price target on the stock.

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $4.00 price target on the stock.

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its hold rating reiterated by analysts at Needham & Company LLC.

Moleculin Biotech (NASDAQ:MBRX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $8.00 price target on the stock.

Mersana Therapeutics (NASDAQ:MRSN) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $4.00 price target on the stock.

Merus (NASDAQ:MRUS) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $85.00 price target on the stock.

Sunnova Energy International (NYSE:NOVA) had its neutral rating reissued by analysts at Robert W. Baird. The firm currently has a $2.00 target price on the stock, down from their previous target price of $9.00.

Nuvalent (NASDAQ:NUVL) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $110.00 price target on the stock.

Owens Corning (NYSE:OC) had its hold rating reiterated by analysts at Benchmark Co..

Onsemi (NASDAQ:ON) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $57.00 price target on the stock.

OPKO Health (NASDAQ:OPK) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $3.00 target price on the stock.

PENN Entertainment (NASDAQ:PENN) had its hold rating reissued by analysts at Benchmark Co..

Palantir Technologies (NASDAQ:PLTR) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $120.00 price target on the stock.

Prime Medicine (NYSE:PRME) had its buy rating reiterated by analysts at Chardan Capital. They currently have a $15.00 price target on the stock.

Prime Medicine (NYSE:PRME) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $10.00 price target on the stock.

Protagonist Therapeutics (NASDAQ:PTGX) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $54.00 price target on the stock.

Sunrun (NASDAQ:RUN) had its hold rating reaffirmed by analysts at Truist Financial Co.. The firm currently has a $9.00 target price on the stock, down from their previous target price of $12.00.

scPharmaceuticals (NASDAQ:SCPH) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $18.00 price target on the stock.

Soleno Therapeutics (NASDAQ:SLNO) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $70.00 price target on the stock.

SoundHound AI (NASDAQ:SOUN) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $26.00 price target on the stock.

ARS Pharmaceuticals (NASDAQ:SPRY) had its outperform rating reiterated by analysts at William Blair.

Sempra (NYSE:SRE) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a $77.00 price target on the stock, down from their previous price target of $96.00.

TKO Group (NYSE:TKO) had its hold rating reaffirmed by analysts at Benchmark Co..

Tandem Diabetes Care (NASDAQ:TNDM) had its equal weight rating reiterated by analysts at Wells Fargo & Company. They currently have a $22.00 target price on the stock, down from their previous target price of $38.00.

Trex (NYSE:TREX) had its buy rating reiterated by analysts at Benchmark Co.. The firm currently has a $80.00 price target on the stock.

Tesla (NASDAQ:TSLA) had its top pick rating reaffirmed by analysts at Morgan Stanley. They currently have a $430.00 target price on the stock.

UWM (NYSE:UWMC) had its neutral rating reiterated by analysts at Wedbush. Wedbush currently has a $6.50 target price on the stock.

Vericel (NASDAQ:VCEL) had its buy rating reissued by analysts at Truist Financial Co.. The firm currently has a $61.00 target price on the stock, down from their previous target price of $67.00.

Voyager Therapeutics (NASDAQ:VYGR) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $30.00 price target on the stock.

TeraWulf (NASDAQ:WULF) had its buy rating reissued by analysts at Rosenblatt Securities. They currently have a $10.00 target price on the stock.

Zai Lab (NASDAQ:ZLAB) had its neutral rating reissued by analysts at Bank of America Co.. The firm currently has a $36.10 target price on the stock, up from their previous target price of $29.00.